Catherine Stehman-Breen - 29 May 2025 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role
Director
Signature
/s/ Jennifer Drimmer Rokovich, Attorney-in-Fact
Issuer symbol
TNYA
Transactions as of
29 May 2025
Net transactions value
$0
Form type
4
Filing time
30 May 2025, 18:54:13 UTC
Previous filing
21 Oct 2024
Next filing
03 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stehman-Breen Catherine Director C/O TENAYA THERAPEUTICS, INC., 171 OYSTER POINT BLVD., 5TH FLOOR, SOUTH SAN FRANCISCO /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact 30 May 2025 0001702233

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNYA Stock Option (Right to buy) Award $0 +107,400 $0.000000 107,400 29 May 2025 Common Stock 107,400 $0.4444 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 29, 2026, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date.